Clarus Therapeutics Holdings, Inc.
Biotechnology company · Los Angeles, California, United States
Clarus Therapeutics Holdings, Inc. is a biotechnology company headquartered in Los Angeles, California, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2021.
Clarus Therapeutics Holdings at a glance
What does Clarus Therapeutics Holdings do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $15 million sold (2021).
Frequently asked questions about Clarus Therapeutics Holdings
Where is Clarus Therapeutics Holdings headquartered?
Clarus Therapeutics Holdings, Inc. is headquartered in Los Angeles, California, United States.
What does Clarus Therapeutics Holdings do?
Clarus Therapeutics Holdings, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
When was Clarus Therapeutics Holdings founded?
The earliest incorporation on record for Clarus Therapeutics Holdings, Inc. is in 2020, according to public company registers.
Similar companies
- LadRx CorpLos Angeles, California, United States
- Spinogenix, Inc.Los Angeles, California, United States
- Armata Pharmaceuticals, Inc.Los Angeles, California, United States
- Partillion Bioscience CorpLos Angeles, California, United States
- Enspire Bio, Inc.Los Angeles, California, United States
- Amydis, Inc.Los Angeles, California, United States
- Uplifting Results Labs, Inc.Los Angeles, California, United States
- Paralos Bioscience Inc.Los Angeles, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences